High-containment biosafety laboratories : preliminary observations on the oversight of the proliferation of BSL-3 and BSL-4 laboratories in the United States : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives /

In response to the global spread of emerging infectious diseases and the threat of bioterrorism, high-containment biosafety laboratories (BSL)--specifically biosafety level (BSL)-3 and BSL-4--have been proliferating in the United States. These labs--classified by the type of agents used and the risk...

Full description

Bibliographic Details
Main Author: Rhodes, Keith A.
Corporate Authors: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations, United States. Government Accountability Office
Format: Government Document eBook
Language:English
Published: [Washington, D.C.] : U.S. Govt. Accountability Office, [2007]
Series:Testimony ; GAO-08-108 T.
Subjects:
Online Access:https://purl.fdlp.gov/GPO/LPS87976
Description
Summary:In response to the global spread of emerging infectious diseases and the threat of bioterrorism, high-containment biosafety laboratories (BSL)--specifically biosafety level (BSL)-3 and BSL-4--have been proliferating in the United States. These labs--classified by the type of agents used and the risk posed to personnel, the environment, and the community--often contain the most dangerous infectious disease agents, such as Ebola, smallpox, and avian influenza. This testimony addresses (1) the extent to which there has been a proliferation of BSL-3 and BSL-4 labs, (2) federal agencies' responsibility for tracking this proliferation and determining the associated risks, and (3) the lessons that can be learned from recent incidents at three high-containment biosafety labs. To address these objectives, GAO asked 12 federal agencies involved with high-containment labs about their missions and whether they tracked the number of labs overall. GAO also reviewed documents from these agencies, such as pertinent legislation, regulation, and guidance. Finally, GAO interviewed academic experts in microbiological research.
Item Description:Title from title screen (viewed on Oct. 5, 2007).
"For release on delivery...October 4, 2007."
Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548.
Electronic resource.
Physical Description:35 pages : digital, PDF file.
Format:Mode of access: Internet. Address as of 10/5/07: http://www.gao.gov/new.items/d08108t.pdf ; current access available via PURL.
Bibliography:Includes bibliographical references.